Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia.
作者信息
Advani Anjali S
机构信息
Cleveland Clinic Lerner College of Medicine, Department of Hematologic Oncology and Blood Disorders, The Cleveland Clinic, Cleveland, Ohio, USA.
出版信息
Clin Adv Hematol Oncol. 2011 Oct;9(10):776-7.
PMID:22252580
Abstract
摘要
Zotero 插件